Stock Events

Profound Medical 

$10.9
2
+$0.09+0.83% Today

Statistics

Day High
-
Day Low
-
52W High
12.98
52W Low
7.11
Volume
1,758
Avg. Volume
37,987
Mkt Cap
265.74M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

8MayExpected
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
-0.51
-0.42
-0.33
-0.24
Expected EPS
-0.41
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PROF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
EDAP TMS.
EDAP
Mkt Cap184.41M
EDAP TMS SA specializes in therapeutic ultrasound and HIFU technologies, directly competing with Profound Medical's TULSA-PRO system.
Intuitive Surgical
ISRG
Mkt Cap161.39B
Intuitive Surgical, Inc. offers robotic-assisted surgical systems, overlapping with Profound Medical's minimally invasive approaches.
Medtronic
MDT
Mkt Cap101.91B
Medtronic plc manufactures and sells device-based medical therapies, including those for prostate health, competing in similar therapeutic areas.
Boston Scientific
BSX
Mkt Cap114.03B
Boston Scientific Corporation develops minimally invasive medical devices, competing in the interventional medicine space.
Globus Medical
GMED
Mkt Cap8.18B
Globus Medical, Inc. focuses on musculoskeletal solutions but also explores technologies that could compete in minimally invasive treatments.
Stryker
SYK
Mkt Cap129.88B
Stryker Corporation specializes in medical technologies across various fields, including surgical devices that could compete with Profound's offerings.
Zimmer Biomet
ZBH
Mkt Cap22.73B
Zimmer Biomet Holdings, Inc. focuses on musculoskeletal healthcare but is expanding into new technologies that could compete with minimally invasive treatments.
Johnson & Johnson
JNJ
Mkt Cap372.29B
Johnson & Johnson engages in the development of medical devices, including surgical systems that could rival Profound Medical's technologies.
Abbott Laboratories
ABT
Mkt Cap177.49B
Abbott Laboratories offers a broad range of medical devices, potentially competing in the same healthcare segments as Profound Medical.

Analyst Ratings

11.4$Average Price Target
The highest estimate is $12.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

About

Health Technology
Medical Specialties
Manufacturing
Surgical and Medical Instrument Manufacturing
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging scanner in hospitals and treatment facilities. The company also offers Sonalleve, a therapeutic platform for the treatment of uterine fibroids and palliative pain relief associated with metastases in bone, as well as non-invasive treatment of uterine fibroids. Profound Medical Corp. is headquartered in Mississauga, Canada.
Show more...
CEO
Employees
131
Country
CA
ISIN
CA74319B5027

Listings